The Food and Drug Administration approves CAR T-Cell therapy Carvykti® as a second-line treatment and the CAR T-Cell therapy Abecma® as a third-line treatment for adult patients with multiple myeloma.

Not-for-profit celebrates past achievements and looks to the future

The annual award honors Roberts’ special service to the patients and families that are served by the ASTCT community.

Global experts will share key insights to help healthcare professionals and researchers improve the lives of patients with blood-related disorders.

Creators of sustained acoustic medicine technology will instruct orthopedic surgeons, sports medicine physicians, physical therapists, and other practitioners in using the sam® X1 ultrasound treatment device.

Presentations at long-running, prestigious meeting will focus on effectiveness of sustained acoustic medicine in soft tissue healing.

When We Tri(al) by TOUCH, The Black Breast Cancer Alliance has partnered with Carebox to provide Breasties, caregivers, and the entire Black community with an easy way to search and match to breast cancer clinical trials.

Now patients, caregivers and healthcare professionals have an easy and effective way to search for and match with gastric cancer clinical trials.

PillSafe® protects the patient with a patented, innovative pill distribution control system that improves dosage safety, prevents prescription drug misuse, and provides potential solutions for the national opioid epidemic.    

CEBIS International Expands Its Comprehensive Preclinical and Clinical Trials Services in 3 Continents

Newest Carebox Connect Clinical Trial Sponsor Website Helps Mirati Therapeutics Deliver on Its Commitment to Patient-Centricity

Company secures funding to fuel expansion of its Thoraguard® System; adds veteran medtech leader Timothy Still to Board of Directors

FIRST INVESTMENT FROM CMTA’S NEW VENTURE PHILANTHROPY ARM

Latham BioPharm Group, part of SIA Partners, today announced receiving a new Indefinite Delivery, Indefinite Quantity (IDIQ) contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), titled Preclinical Services for Biopharmaceuticals Product Development.

Florence Healthcare, the leading provider of Site Enablement Platforms for clinical trials, announced today that it has acquired VersaTrial, a cutting-edge clinical trial solutions provider.

The Oct. 2-3 hybrid workshop will bridge the gap between critical stakeholders to pinpoint today's challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.

Sustained acoustic medicine provides proven soft tissue healing via ZetrOZ's patented wearable ultrasound unit.

AVEO Vapor Devices, a pioneering manufacturer and supplier specializing in vape devices tailored for the cannabis industry, is pleased to announce the acquisition of licensing rights for two patents: US Patent No. US 9,999,254 B2 and Chinese Patent No. CN 206119181U.

Unmet Needs and Elevated Risk of Depression: The Challenges Faced by Caregivers of Noncancerous Brain Tumor Survivors

PA-based clinical technology provider assisTek has announced new features to its upcoming software release, including AI Integration, a Proprietary OS, SSO & Remote Provisioning, to add to its growing suite of eCOA & ePRO solutions.

The Parkinson's disease market is expected to grow to $12.8 billion by 2028.

CA CURE - its FY23 campaign - was the biggest in its 60-year history and will continue in the coming year.

Presentation to Focus on Estrogen Androgen Priming Protocol Improving IVF Response

Beginning in the second quarter of 2023, NIT will provide Actinium-225 in millicurie quantities, marking a significant step forward in cancer treatment

Now patients, caregivers and healthcare professionals have an easy and effective way to search and match to scleroderma clinical trials.

Sustained acoustic medicine delivered by wearable ultrasound device and topical diclofenac patch reduced patients' pain and improved clinical outcomes beyond traditional patient care.

Displayed the advantages of the sam X1 device as a faster way for patients to repair and recover from soft-tissue injuries before returning to work or play.

Dr. Claude Bouchard and Monique Chagnon pledge $1M to support postdoctoral fellows

The company plans to leverage its platform technology to improve access and quality to medical EEG testing and to enable and improve adjacent biomedical research and clinical trials.

Enhanced FDA reporting, full IQ/OQ package & incubator monitoring sensor round out Lab21 offerings

AmplifyBio is adding manufacturing services, starting with cell therapy and plasmids, to its growing capabilities to support the safe development of advanced therapies.

Yang Yang, PhD, of Purdue University is the recipient of a major 5-year grant for Personalized Treatment Development in SCN2A-Related Disorders

The $50,000 Vilcek Prizes for Creative Promise recognize rising immigrant scientists living and working in the United States whose work represents a significant contribution to their field.

The SYNGAP1 Gene: Seeking Treatments and the Genetic Link to Related Neurological Disorders

After successfully completing a project in RNA splicing in cancer this January, BioMed X and Merck continue their oncology collaboration to explore tumor immunogenicity enhancers.